| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | T-705 (Favipiravir) |
|---|
| Description | T-705 (Favipiravir) is an antiviral drug that selectively inhibits the RNA-dependent RNA polymerase of influenza virus. It is phosphoribosylated by cellular enzymes to its active form, favipiravir-ribofuranosyl-5'-triphosphate (RTP). Favipiravir is active against a broad range of influenza viruses, including A(H1N1)pdm09, A(H5N1) and the recently emerged A(H7N9) avian virus. It also inhibits influenza strains resistant to current antiviral drugs, and shows a synergistic effect in combination with oseltamivir, thereby expanding influenza treatment options. Recently, T-705 has been shown to give 100% protection against aerosol Ebola virus E718 infection in immune-deficient mice as well as inhibiting Ebola virus infection in cell culture. MW: |
|---|
| Size | 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 6-Fluoro-3-hydroxy-2-pyrazinecarboxamide; Avigan |
|---|
| Gene, Accession, CAS # | CAS: 259793-96-9 |
|---|
| Catalog # | 2778-25 |
|---|
| Price | |
|---|
| Order / More Info | T-705 (Favipiravir) from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|